Abstract
Neuroendocrine tumours (NETs) may arise from the gastrointestinal tract and pancreas (collectively known as gastroenteropancreatic neuroendocrine tumours, GEP-NETs) and from neuroendocrine cells scattered in other tissues. Non-functioning tumours, in which there is no recognisable clinical syndrome, often present late with symptoms due to mass effect, although small non-functioning lesions may be detected when screening family groups with genetic disorders associated with NETs. Functioning tumours usually present relatively early due to clinical symptoms but may be a challenge to localise as they are often small. The malignant potential of NETs varies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McCook TA, Putman CE, Dale JK, Wells SA (1982) Review: Medullary carcinoma of the thyroid: radiographic features of a unique tumor. AJR Am J Roentgenol 139(1):149–155
Vinik AI, Woltering EA, Warner RR, Caplin M, O’Dorisio TM, Wiseman GA et al (2010) NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39(6):713–734
Kim SH, Kim BS, Jung SL, Lee JW, Yang PS, Kang BJ et al (2009) Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean J Radiol Off J Korean Radiol Soc 10(2):101–105
Elisei R (2008) Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22(6):941–953
Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C et al (2006) Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29(5):427–437
Aiken AH (2012) Imaging of thyroid cancer. Semin Ultrasound CT MR 33(2):138–149
Wang Q, Takashima S, Fukuda H, Takayama F, Kobayashi S, Sone S (1999) Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 125(8):842–848
Nader S, Hickey RC, Sellin RV, Samaan NA (1983) Adrenal cortical carcinoma. A study of 77 cases. Cancer 52(4):707–711
Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72(11):3145–3155
Reznek RH, Narayanan P (2010) Primary adrenal malignancy. In: Reznek RH, Husband J (eds) Husband & Reznek’s imaging in oncology, 3rd edn. Informa Healthcare, London, pp 280–298
Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027–2037
Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4):711–736
Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS (1987) Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 148(3):531–535
Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322(17):1195–1201
Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF, Abrams HL (1985) Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 144(1):61–65
Rockall AG, Babar SA, Sohaib SA, Isidori AM, Diaz-Cano S, Monson JP et al (2004) CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome. Radiographics Rev Publ Radiol Soc North Am Inc 24(2):435–452
Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204
Schlund JF, Kenney PJ, Brown ED, Ascher SM, Brown JJ, Semelka RC (1995) Adrenocortical carcinoma: MR imaging appearance with current techniques. JMRI 5(2):171–174
Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K (2007) The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14(3):587–599
Ferrozzi F, Bova D (1995) CT and MR demonstration of fat within an adrenal cortical carcinoma. Abdom Imaging 20(3):272–274
Faria JF, Goldman SM, Szejnfeld J, Melo H, Kater C, Kenney P et al (2007) Adrenal masses: characterization with in vivo proton MR spectroscopy–initial experience. Radiology 245(3):788–797
Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics Rev Publ Radiol Soc North Am Inc 21(4):995–1012
Jacques AE, Sahdev A, Sandrasagara M, Goldstein R, Berney D, Rockall AG et al (2008) Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18(12):2885–2892
Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB et al (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol 196(6):W706–W714
Bowerman RA, Silver TM, Jaffe MH, Stuck KJ, Hinerman DL (1981) Sonography of adrenal pheochromocytomas. AJR Am J Roentgenol 137(6):1227–1231
Blake MA, Krishnamoorthy SK, Boland GW, Sweeney AT, Pitman MB, Harisinghani M et al (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 181(6):1663–1668
Szolar DH, Kammerhuber FH (1998) Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 207(2):369–375
Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H et al (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2):479–485
Park BK, Kim CK, Kwon GY, Kim JH (2007) Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 17(11):2804–2809
Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A et al (2004) Adrenal masses: mr imaging features with pathologic correlation. Radiographics Rev Publ Radiol Soc North Am Inc 24(Suppl 1):S73–S86
Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR et al (2004) Pheochromocytoma: an imaging chameleon. Radiographics Rev Publ Radiol Soc North Am Inc 24(Suppl 1):S87–S99
Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171(3):675–680
Lee KY, Oh YW, Noh HJ, Lee YJ, Yong HS, Kang EY et al (2006) Extraadrenal paragangliomas of the body: imaging features. AJR Am J Roentgenol 187(2):492–504
Magliulo G, Zardo F, Varacalli S, D’Amico R (2003) Multiple paragangliomas of the head and neck. An Otorrinolaringol Ibero Am 30(1):31–38
Duncan AW, Lack EE, Deck MF (1979) Radiological evaluation of paragangliomas of the head and neck. Radiology 132(1):99–105
Som PM, Sacher M, Stollman AL, Biller HF, Lawson W (1988) Common tumors of the parapharyngeal space: refined imaging diagnosis. Radiology 169(1):81–85
Olsen WL, Dillon WP, Kelly WM, Norman D, Brant-Zawadzki M, Newton TH (1987) MR imaging of paragangliomas. AJR Am J Roentgenol 148(1):201–204
A ST (1989) Paragangliomas. In: Sternberg SS (ed) Diagnostic surgical pathology. Raven Press, New York, pp 467–477
Rakovich G, Ferraro P, Therasse E, Duranceau A (2001) Preoperative embolization in the management of a mediastinal paraganglioma. Ann Thorac Surg 72(2):601–603
Sahin-Akyar G, Erden I, Yagci C, Akyar S, Erekul S (1997) Magnetic resonance imaging findings of a nonfunctional mediastinal paraganglioma with an unusual presentation. Eur Radiol 7(7):1114–1116
Hayes WS, Davidson AJ, Grimley PM, Hartman DS (1990) Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. AJR Am J Roentgenol 155(6):1247–1250
van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG et al (1991) MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics Rev Publ Radiol Soc North Am Inc 11(1):37–57
Aldridge MC, Williamson RC (1996) Surgery of endocrine tumours of the pancreas. In: Lynn J, Bloom SR (eds) Surgical endocrinology. Butterworth-Heinemann, Oxford, pp 503–518
van Heerden JA, Grant CS, Czako PF (1992) Occult functioning insulinomas: which localizing studies are indicated? Surgery 112:1010–1015
Stark DD, Moss AA, Goldberg HI, Deveney CW (1984) CT of pancreatic islet cell tumors. Radiology 150(2):491–494
Service FJ, Dale AJ, Elveback LR, Jiang NS (1976) Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51(7):417–429
Berends FJ, Cuesta MA, Kazemier G, van Eijck CH, de Herder WW, van Muiswinkel JM et al (2000) Laparoscopic detection and resection of insulinomas. Surgery 128(3):386–391
Kent RB III, van Heerden JA, Weiland LH (1981) Nonfunctioning islet cell tumors. Ann Surg 193(2):185–190
Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F et al (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol Off J Am Soc Clin Oncol 17(2):615–630
Alexander HR, Jensen RT (2001) Pancreatic endocrine tumors. In: Devita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 1788–1813
Doppman JL, Shawker TH, Miller DL (1989) Localization of islet cell tumors. Gastroenterol Clin North Am 18(4):793–804
King CM, Reznek RH, Dacie JE, Wass JA (1994) Imaging islet cell tumours. Clin Radiol 49(5):295–303
Hammond PJ, Jackson JA, Bloom SR (1994) Localization of pancreatic endocrine tumours. Clin Endocrinol (Oxf) 40(1):3–14
Vinik AI, Strodel WE, Eckhauser FE, Moattari AR, Lloyd R (1987) Somatostatinomas, PPomas, neurotensinomas. Semin Oncol 14(3):263–281
Grant CS (1999) Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am 28(3):533–554
Bottger TC, Weber W, Beyer J, Junginger T (1990) Value of tumor localization in patients with insulinoma. World J Surg 14(1):107–112
London JF, Shawker TH, Doppman JL, Frucht HH, Vinayek R, Stark HA et al (1991) Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas. Radiology 178(3):763–767
Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M (2008) Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 6(5):590–597
Oshikawa O, Tanaka S, Ioka T, Nakaizumi A, Hamada Y, Mitani T (2002) Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol 178(5):1133–1137
Rickes S, Monkemuller K, Malfertheiner P (2006) Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP J Pancreas 7(6):584–592
Sundin A, Vullierme MP, Kaltsas G, Plockinger U (2009) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations. Neuroendocrinology 90(2):167–183
Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM (2000) Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95(9):2271–2277
Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K et al (1992) Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326(26):1721–1726
Fein J, Gerdes H (1992) Localization of islet cell tumors by endoscopic ultrasonography. Gastroenterology 103(2):711–712
Ueno N, Tomiyama T, Tano S, Wada S, Aizawa T, Kimura K (1996) Utility of endoscopic ultrasonography with color Doppler function for the diagnosis of islet cell tumor. Am J Gastroenterol 91(4):772–776
Baker MS, Knuth JL, DeWitt J, LeBlanc J, Cramer H, Howard TJ et al (2008) Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. J Gastrointest Surg 12(3):450–456
Chang F, van der Walt J (2006) Fine needle aspiration and core biopsy from a 43-year-old man with multiple abdominal masses. Cytopathology 17(5):307–310
Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR et al (2008) Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg 247(1):165–172
Norton JA, Cromack DT, Shawker TH, Doppman JL, Comi R, Gorden P et al (1988) Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 207(2):160–168
Buetow PC, Parrino TV, Buck JL, Pantongrag-Brown L, Ros PR, Dachman AH et al (1995) Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol 165(5):1175–1179
Fidler JL, Fletcher JG, Reading CC, Andrews JC, Thompson GB, Grant CS et al (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol 181(3):775–780
Stafford-Johnson DB, Francis IR, Eckhauser FE, Knol JA, Chang AE (1998) Dual-phase helical CT of nonfunctioning islet cell tumors. J Comput Assist Tomogr 22(2):335–339
Van Hoe L, Gryspeerdt S, Marchal G, Baert AL, Mertens L (1995) Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR Am J Roentgenol 165(6):1437–1439
Chung MJ, Choi BI, Han JK, Chung JW, Han MC, Bae SH (1997) Functioning islet cell tumor of the pancreas. Localization with dynamic spiral CT. Acta Radiol 38(1):135–138
Ichikawa T, Peterson MS, Federle MP, Baron RL, Haradome H, Kawamori Y et al (2000) Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216(1):163–171
Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA (2002) Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg 6(1):66–74
Imaoka H, Yamao K, Salem AA, Sawaki A, Takahashi K, Mizuno N et al (2005) Pancreatic endocrine neoplasm can mimic serous cystadenoma. Int J Gastrointest Cancer 35(3):217–220
Wank SA, Doppman JL, Miller DL, Collen MJ, Maton PN, Vinayek R et al (1987) Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology 92(4):905–912
Maton PN, Miller DL, Doppman JL, Collen MJ, Norton JA, Vinayek R et al (1987) Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. Gastroenterology 92(4):913–918
Owen NJ, Sohaib SA, Peppercorn PD, Monson JP, Grossman AB, Besser GM et al (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74(886):968–973
Semelka RC, Custodio CM, Cem BN, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 11(2):141–148
Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB (2000) Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 214(2):483–490
Pisegna JR, Doppman JL, Norton JA, Metz DC, Jensen RT (1993) Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 38(7):1318–1328
Rockall AG, Planche K, Power N, Nowosinska E, Monson JP, Grossman AB et al (2009) Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI. Neuroendocrinology 89(3):288–295
Wang C (1998) Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Acta Radiol Suppl 415:1–31
Wang Y, Miller FH, Chen ZE, Merrick L, Mortele KJ, Hoff FL et al (2011) Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas. Radiographics Rev Publ Radiol Soc North Am Inc 31(3):E47–E64
Williams ED, Sandler M (1963) The classification of carcinoid tumours. Lancet 1(7275):238–239
Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL (1985) Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 55(6):1303–1311
Colby TV, Koss MN, Travis WD (1995) Carcinoid and other neuroendocrine tumors. In: Colby TV, Koss MN, Travis WD (eds) Atlas to tumor pathology: tumors of the lower respiratory tract. Armed Forces Institute of Pathology, Washington, DC, pp 287–317
Beasley MB, Brambilla E, Travis WD (2005) The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 40(2):90–97
Jeung MY, Gasser B, Gangi A, Charneau D, Ducroq X, Kessler R et al (2002) Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings. Radiographics Rev Publ Radiol Soc North Am Inc 22(2):351–365
Nessi R, Basso RP, Basso RS, Bosco M, Blanc M, Uslenghi C (1991) Bronchial carcinoid tumors: radiologic observations in 49 cases. J Thorac Imaging 6(2):47–53
Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM et al (1991) Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR Am J Roentgenol 156(1):39–43
Dusmet ME, McKneally MF (1996) Pulmonary and thymic carcinoid tumors. World J Surg 20(2):189–195
Wollensak G, Herbst EW, Beck A, Schaefer HE (1992) Primary thymic carcinoid with Cushing’s syndrome. Virchows Arch A Pathol Anat Histopathol 420(2):191–195
Brown LR, Aughenbaugh GL, Wick MR, Baker BA, Salassa RM (1982) Roentgenologic diagnosis of primary corticotropin-producing carcinoid tumors of the mediastinum. Radiology 142(1):143–148
Wang DY, Chang DB, Kuo SH, Yang PC, Lee YC, Hsu HC et al (1994) Carcinoid tumours of the thymus. Thorax 49(4):357–360
Brown LR, Aughenbaugh GL (1991) Masses of the anterior mediastinum: CT and MR imaging. AJR Am J Roentgenol 157(6):1171–1180
Fujiwara K, Segawa Y, Takigawa N, Kishino D, Ida M, Eguchi K et al (2000) Two cases of atypical carcinoid of the thymus. Intern Med 39(10):834–838
Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20(2):168–172
Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG (2001) Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol 176(4):947–951
Sahani DV, Bonaffini PA, Fernandez-Del Castillo C, Blake MA (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61
Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959
Burke AP, Thomas RM, Elsayed AM, Sobin LH (1997) Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 79(6):1086–1093
Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79(4):813–829
Jensen RT, Doherty GM (2001) Carcinoid tumors and the carcinoid syndrome. In: Devita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 1813–1833
Woodard PK, Feldman JM, Paine SS, Baker ME (1995) Midgut carcinoid tumors: CT findings and biochemical profiles. J Comput Assist Tomogr 19(3):400–405
Sugimoto E, Lorelius LE, Eriksson B, Oberg K (1995) Midgut carcinoid tumours. CT appearance. Acta Radiol 36(4):367–371
Romano S, De Lutio E, Rollandi GA, Romano L, Grassi R, Maglinte DD (2005) Multidetector computed tomography enteroclysis (MDCT-E) with neutral enteral and IV contrast enhancement in tumor detection. Eur Radiol 15(6):1178–1183
Hristova L, Place V, Nemeth J, Boudiaf M, Laurent V, Soyer P (2012) Small bowel tumors: spectrum of findings on 64-section CT enteroclysis with pathologic correlation. Clin Imaging 36(2):104–112
Kamaoui I, De-Luca V, Ficarelli S, Mennesson N, Lombard-Bohas C, Pilleul F (2010) Value of CT enteroclysis in suspected small-bowel carcinoid tumors. AJR Am J Roentgenol 194(3):629–633
Pilleul F, Penigaud M, Milot L, Saurin JC, Chayvialle JA, Valette PJ (2006) Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241(3):796–801
Lewis BS, Eisen GM, Friedman S (2005) A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 37(10):960–965
Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT (2001) MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. J Magn Reson Imag JMRI 14(3):261–269
Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL (1995) Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR Am J Roentgenol 164(2):387–391
Amzallag-Bellenger E, Oudjit A, Ruiz A, Cadiot G, Soyer PA, Hoeffel CC (2012) Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease. Radiographics Rev Publ Radiol Soc North Am Inc 32(5):1423–1444
Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N (2001) MR enteroclysis imaging of Crohn disease. Radiographics Rev Publ Radiol Soc North Am Inc 21 Spec No:S161–S172
Masselli G, Vecchioli A, Gualdi GF (2006) Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom Imaging 31(4):400–409
Fidler J (2007) MR imaging of the small bowel. Radiol Clin North Am 45(2):317–331
Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Marano P (2004) Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 29(3):326–334
Maglinte DD, Lappas JC, Sandrasegaran K (2008) Malignant tumours of the small bowel. In: Gore R, Levine M (eds) Textbook of gastrointestinal radiology, 3rd edn. Saunders Elsevier, Philadelphia, pp 853–869
Hoeffel C, Crema MD, Belkacem A, Azizi L, Lewin M, Arrive L et al (2006) Multi-detector row CT: spectrum of diseases involving the ileocecal area. Radiographics Rev Publ Radiol Soc North Am Inc 26(5):1373–1390
Van Weyenberg SJ, Meijerink MR, Jacobs MA, Van der Peet DL, Van Kuijk C, Mulder CJ et al (2010) MR enteroclysis in the diagnosis of small-bowel neoplasms. Radiology 254(3):765–773
Semelka RC, John G, Kelekis NL, Burdeny DA, Ascher SM (1996) Small bowel neoplastic disease: demonstration by MRI. J Magn Reson Imag JMRI 6(6):855–860
Winburn GB (1998) Multiple rectal carcinoids: a case report. Am Surg 64(12):1200–1203
Koura AN, Giacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM (1997) Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer 79(7):1294–1298
Danikas D, Theodorou SJ, Matthews WE, Rienzo AA (2000) Unusually aggressive rectal carcinoid metastasizing to larynx, pancreas, adrenal glands, and brain. Am Surg 66(12):1179–1180
Maeda K, Maruta M, Utsumi T, Sato H, Masumori K, Matsumoto M (2002) Minimally invasive surgery for carcinoid tumors in the rectum. Biomed Pharmacother 56(Suppl 1):222s–226s
Schindl M, Niederle B, Hafner M, Teleky B, Langle F, Kaserer K et al (1998) Stage-dependent therapy of rectal carcinoid tumors. World J Surg 22(6):628–633
Matsumoto T, Iida M, Suekane H, Tominaga M, Yao T, Fujishima M (1991) Endoscopic ultrasonography in rectal carcinoid tumors: contribution to selection of therapy. Gastrointest Endosc 37(5):539–542
Berge T, Linell F (1976) Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta pathologica et microbiologica Scandinavica Section A Pathology 84(4):322–330
Rickes S, Ocran KW, Gerstenhauer G, Neye H, Wermke W (2004) Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Dis (Basel, Switzerland) 22(1):81–86
Giesel FL, Wulfert S, Zechmann CM, Haberkorn U, Kratochwil C, Flechsig P et al (2013) Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy. Exp Oncol 35(2):122–126
Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC (1998) Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 206(1):143–150
d’Assignies G, Fina P, Bruno O, Vullierme MP, Tubach F, Paradis V et al (2013) High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology 268(2):390–399
Torabi M, Aquino SL, Harisinghani MG (2004) Current concepts in lymph node imaging. J Nucl Med Off Publ Soc Nucl Med 45(9):1509–1518
Gibril F, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F et al (1998) Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management. J Clin Oncol Off J Am Soc Clin Oncol 16(3):1040–1053
Leboulleux S, Dromain C, Vataire AL, Malka D, Auperin A, Lumbroso J et al (2008) Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. J Clin Endocrinol Metab 93(8):3021–3028
Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Feugeas MC et al (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070
Sundin A, Rockall A (2012) Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology 96(4):261–271
Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S et al (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics Rev Publ Radiol Soc North Am Inc 21 Spec No:S41–S54
Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA et al (2008) Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol 190(1):67–73
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hameed, S., Wills, M., Rockall, A. (2015). Cross-Sectional Imaging of Neuroendocrine Tumours. In: Yalcin, S., Öberg, K. (eds) Neuroendocrine Tumours. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45215-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-45215-8_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45214-1
Online ISBN: 978-3-662-45215-8
eBook Packages: MedicineMedicine (R0)